首页    期刊浏览 2024年08月31日 星期六
登录注册

文章基本信息

  • 标题:Amorphigenin inhibits Osteoclast differentiation by suppressing c-Fos and nuclear factor of activated T cells
  • 本地全文:下载
  • 作者:Kim, Bong Gyu ; Kwak, Han Bok ; Choi, Eun-Yong
  • 期刊名称:Anatomy & Cell Biology
  • 印刷版ISSN:2093-3665
  • 出版年度:2010
  • 卷号:43
  • 期号:4
  • 页码:310-316
  • DOI:10.5115/acb.2010.43.4.310
  • 语种:English
  • 出版社:Anatomy and Cell Biology
  • 摘要:

    Among the several rotenoids, amorphigenin is isolated from the leaves of Amopha Fruticosa and it is known that has anti-proliferative effects and anti-cnacer effects in many cell types. The main aim of this study was to investigate the effects of amorphigenin on osteoclast differentiation in vitro and on LPS treated inflammatory bone loss model in vivo. We show here that amorphigenin inhibited RANKL-induced osteoclast differentiation from bone marrow macrophages in a dose dependent manner without cellular toxicity. Anti-osteoclastogenic properties of amorphigenin were based on a down-regulation of c-fos and NFATc1. Amorphigenin markedly inhibited RANKL-induced p38 and NF-κB pathways, but other pathways were not affected. Micro-CT analysis of the femurs showed that amorphigenin protected the LPS-induced bone loss. We concluded that amorphigenin can prevent inflammation-induced bone loss. Thus we expect that amorphigenin could be a treatment option for bone erosion caused by inflammation.

  • 关键词:Osteoporosis; Osteoclast; NFATc1
国家哲学社会科学文献中心版权所有